Mankind Pharma Appoints Anish Vanraj Bafna as Independent Director

Mankind Pharma Ltd announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director. The appointment, effective August 10, 2026, was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Bafna's appointment is for a term of 5 years, subject to shareholder approval via postal ballot. He brings over 30 years of experience in the healthcare and medical devices sector, including leadership roles at Healthium Medtech Limited and Baxter International. Mr. Bafna is not related to any existing directors or promoters and meets the independence criteria.